Dis-Chem veteran Stanley Goetsch exits after 42 years, offloads $4.8 million stake

Dis-Chem Pharmacies, one of Africa’s leading pharmaceutical retail groups, founded by the South African billionaire Saltzman family, announced the resignation of its long-serving director and veteran Stanley Goetsch, who will resign after 42 years, marking a significant leadership transition at one of South Africa’s largest healthcare retailers.

Goetsch, a key figure in Dis-Chem’s transformation journey from a small pharmacy business into a listed retail powerhouse, ahead of his retirement, has executed so far an insider sale worth R82.58 million ($4.82 million) at an average price of R36 per share, signaling a gradual monetization of long-held equity accumulated over decades of value creation.

Insider sale signals planned transition
The transaction ranks among the largest insider share sales in Dis-Chem this year and reflects a structured exit strategy ahead of retirement. While such disposals are common among long-serving executives, the timing underscores a broader leadership shift within South Africa’s retail pharmacy sector.

Dis-Chem’s board acknowledged Goetsch’s contribution, highlighting his role in shaping strategy, strengthening operations, and expanding the company’s national footprint across pharmacies, clinics, and front-shop retail.

Four decades of growth and expansion
Founded as a family-run pharmacy, Dis-Chem has evolved into a major listed healthcare retailer with strong institutional backing. Goetsch’s tenure spanned this transformation, helping drive expansion, supply chain development, and customer-centric retail execution.

His leadership coincided with the increasing formalization of South Africa’s healthcare retail market, where scale, pricing efficiency, and distribution capabilities have become critical competitive advantages.

Industry competition intensifies
Goetsch’s departure comes as the sector undergoes rapid change, with competitors investing in digital health platforms, private-label products, and logistics optimization to capture market share.

The shift reflects broader structural changes across African retail, where companies are transitioning from founder-led models to institutionally driven growth strategies.

Focus shifts to continuity
Dis-Chem has yet to name a replacement, but the transition is expected to be managed internally to ensure operational stability.

For the company, the challenge will be sustaining growth momentum while preserving the disciplined execution and customer focus that defined Goetsch’s tenure.

His exit marks the end of an era and the beginning of a new phase for one of South Africa’s most influential healthcare retailers.